{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:18:32Z","timestamp":1792275512783,"version":"4.4.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/INF\/22\/SP42551\/2021"],"award-info":[{"award-number":["BT\/INF\/22\/SP42551\/2021"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/INF\/22\/SP42551\/2021"],"award-info":[{"award-number":["BT\/INF\/22\/SP42551\/2021"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11030-024-10837-5","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T19:01:37Z","timestamp":1713466897000},"page":"117-137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Fragment-based discovery of new potential DNMT1 inhibitors integrating multiple pharmacophore modeling, 3D-QSAR, virtual screening, molecular docking, ADME, and molecular dynamics simulation approaches"],"prefix":"10.1007","volume":"29","author":[{"given":"Goverdhan","family":"Lanka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvankar","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilanjan","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaram","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,18]]},"reference":[{"issue":"6990","key":"10837_CR1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature02625","volume":"429","author":"G Egger","year":"2004","unstructured":"Egger G, Liang G, Aparicio A, Jones PA (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429(6990):457\u2013463. https:\/\/doi.org\/10.1038\/nature02625","journal-title":"Nature"},{"issue":"6","key":"10837_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrg816","volume":"3","author":"PA Jones","year":"2002","unstructured":"Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3(6):415\u2013428. https:\/\/doi.org\/10.1038\/nrg816","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10837_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/npp.2012.112","volume":"38","author":"LD Moore","year":"2013","unstructured":"Moore LD, Le T, Fan G (2013) DNA methylation and its basic function. Neuropsychopharmacol 38(1):23\u201338. https:\/\/doi.org\/10.1038\/npp.2012.112","journal-title":"Neuropsychopharmacol"},{"issue":"2","key":"10837_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/cbic.201000195","volume":"12","author":"RZ Jurkowska","year":"2011","unstructured":"Jurkowska RZ, Jurkowski TP, Jeltsch A (2011) Structure and function of mammalian DNA methyltransferases. ChemBioChem 12(2):206\u2013222. https:\/\/doi.org\/10.1002\/cbic.201000195","journal-title":"ChemBioChem"},{"issue":"46","key":"10837_CR5","doi-asserted-by":"publisher","first-page":"48350","DOI":"10.1074\/jbc.M403427200","volume":"279","author":"A Hermann","year":"2004","unstructured":"Hermann A, Goyal R, Jeltsch A (2004) The DNMT1 DNA-(Cytosine-C5)-Methyltransferase methylates DNA processively with high preference for hemimethylated target sites. J Biol Chem 279(46):48350\u201348359. https:\/\/doi.org\/10.1074\/jbc.M403427200","journal-title":"J Biol Chem"},{"key":"10837_CR6","doi-asserted-by":"publisher","unstructured":"Jin B, Robertson KD (2013) DNA methyltransferases, DNA damage repair, and cancer, In: Karpf AR (ed) Epigenetic alterations in oncogenesis, Springer, New York, vol 754, pp 3\u201329. https:\/\/doi.org\/10.1007\/978-1-4419-9967-2_1","DOI":"10.1007\/978-1-4419-9967-2_1"},{"key":"10837_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fonc.2014.00080","volume":"4","author":"D Subramaniam","year":"2014","unstructured":"Subramaniam D, Thombre R, Dhar A, Anant S (2014) DNA methyltransferases: A novel target for prevention and therapy. Front Oncol 4:80. https:\/\/doi.org\/10.3389\/fonc.2014.00080","journal-title":"Front Oncol"},{"key":"10837_CR8","doi-asserted-by":"publisher","unstructured":"Jeltsch A (2006) Molecular enzymology of mammalian DNA methyltransferases. In: Doerfler W, B\u00f6hm P (eds) DNA methylation: basic mechanisms, Springer, Berlin, vol 301, pp 203\u2013225. https:\/\/doi.org\/10.1007\/3-540-31390-7_7.","DOI":"10.1007\/3-540-31390-7_7"},{"issue":"5","key":"10837_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-017-0081-z","volume":"20","author":"W Zhang","year":"2017","unstructured":"Zhang W, Xu J (2017) DNA methyltransferases and their roles in tumorigenesis. Biomark Res 20(5):1. https:\/\/doi.org\/10.1186\/s40364-017-0081-z","journal-title":"Biomark Res"},{"key":"10837_CR10","first-page":"458","volume":"19","author":"C Phanus-Umporn","year":"2020","unstructured":"Phanus-Umporn C, Prachayasittikul V, Nantasenamat C, Prachayasittikul S, Prachayasittikul V (2020) QSAR-driven rational design of novel DNA methyltransferase 1 inhibitors. EXCLI J. 19:458\u2013475","journal-title":"EXCLI J."},{"issue":"2","key":"10837_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11030-013-9428-z","volume":"17","author":"JL Medina-Franco","year":"2013","unstructured":"Medina-Franco JL, Yoo J (2013) Docking of a novel DNA methyltransferase inhibitor identified from high-throughput screening: insights to unveil inhibitors in chemical databases. Mol Divers 17(2):337\u2013344. https:\/\/doi.org\/10.1007\/s11030-013-9428-z","journal-title":"Mol Divers"},{"issue":"24","key":"10837_CR12","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1038\/sj.onc.1204341","volume":"20","author":"KD Robertson","year":"2001","unstructured":"Robertson KD (2001) DNA methylation, methyltransferases, and cancer. Oncogene 20(24):3139\u20133155. https:\/\/doi.org\/10.1038\/sj.onc.1204341","journal-title":"Oncogene"},{"issue":"4","key":"10837_CR13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00418-022-02173-2","volume":"159","author":"G Sukur","year":"2023","unstructured":"Sukur G, Uysal F, Cinar O (2023) High-fat diet induced obesity alters dnmt1 and dnmt3a levels and global DNA methylation in mouse ovary and testis. Histochem Cell Biol 159(4):339\u2013352. https:\/\/doi.org\/10.1007\/s00418-022-02173-2","journal-title":"Histochem Cell Biol"},{"key":"10837_CR14","doi-asserted-by":"publisher","unstructured":"AmruthMaroju P, NagaMohan K (2022) DNA methyltransferases and schizophrenia: current status. In: Fukao K (ed) Psychosis - phenomenology, psychopathology and pathophysiology, IntechOpen, 2022. https:\/\/doi.org\/10.5772\/intechopen.98567.","DOI":"10.5772\/intechopen.98567"},{"key":"10837_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.semcancer.2020.05.010","volume":"72","author":"KK Wong","year":"2021","unstructured":"Wong KK (2021) DNMT1: A key drug target in triple-negative breast cancer. Semin Cancer Biol 72:198\u2013213. https:\/\/doi.org\/10.1016\/j.semcancer.2020.05.010","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"10837_CR16","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.urolonc.2012.03.015","volume":"31","author":"D Dhawan","year":"2013","unstructured":"Dhawan D, Ramos-Vara JA, Hahn NM, Waddell J, Olbricht GR, Zheng R, Stewart JC, Knapp DW (2013) DNMT1: an emerging target in the treatment of invasive urinary bladder cancer. Semin Orig Investig 31(8):1761\u20131769. https:\/\/doi.org\/10.1016\/j.urolonc.2012.03.015","journal-title":"Semin Orig Investig"},{"issue":"5","key":"10837_CR17","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s13402-020-00526-4","volume":"43","author":"KK Wong","year":"2020","unstructured":"Wong KK (2020) DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implications. Cell Oncol 43(5):779\u2013792. https:\/\/doi.org\/10.1007\/s13402-020-00526-4","journal-title":"Cell Oncol"},{"issue":"1","key":"10837_CR18","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1080\/07853890.2022.2099578","volume":"54","author":"M Li","year":"2022","unstructured":"Li M, Zhang D (2022) DNA methyltransferase-1 in acute myeloid leukaemia: beyond the maintenance of DNA methylation. Ann Med 54(1):2011\u20132023. https:\/\/doi.org\/10.1080\/07853890.2022.2099578","journal-title":"Ann Med"},{"issue":"8","key":"10837_CR19","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1442-2050.2011.01199.x","volume":"24","author":"SL Zhao","year":"2011","unstructured":"Zhao SL, Zhu ST, Hao X, Li P, Zhang ZT (2011) Effects of DNA methyltransferase 1 inhibition on esophageal squamous cell carcinoma: the role of DNMT1 in ESCC. Diseas Esophagus 24(8):601\u2013610. https:\/\/doi.org\/10.1111\/j.1442-2050.2011.01199.x","journal-title":"Diseas Esophagus"},{"issue":"1\u20133","key":"10837_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.schres.2014.10.030","volume":"167","author":"E Dong","year":"2015","unstructured":"Dong E, Ruzicka WB, Grayson DR, Guidotti A (2015) DNA-Methyltransferase1 (DNMT1) binding to CpG Rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients. Schizophrenia Res 167(1\u20133):35\u201341. https:\/\/doi.org\/10.1016\/j.schres.2014.10.030","journal-title":"Schizophrenia Res"},{"issue":"21","key":"10837_CR21","doi-asserted-by":"publisher","first-page":"9028","DOI":"10.1021\/jm501134e","volume":"57","author":"S Chen","year":"2014","unstructured":"Chen S, Wang Y, Zhou W, Li S, Peng J, Shi Z, Hu J, Liu YC, Ding H, Lin Y, Li L, Cheng S, Liu J, Lu T, Jiang H, Liu B, Zheng M, Luo C (2014) Identifying novel selective non-nucleoside DNA methyltransferase 1 Inhibitors through docking-based virtual screening. J Med Chem 57(21):9028\u20139041. https:\/\/doi.org\/10.1021\/jm501134e","journal-title":"J Med Chem"},{"issue":"1","key":"10837_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s13148-021-01154-x","volume":"13","author":"C Hu","year":"2021","unstructured":"Hu C, Liu X, Zeng Y, Liu J, Wu F (2021) DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application. Clin Epigenet 13(1):166. https:\/\/doi.org\/10.1186\/s13148-021-01154-x","journal-title":"Clin Epigenet"},{"issue":"20","key":"10837_CR23","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1093\/jnci\/dji311","volume":"33","author":"A Gnyszka","year":"2013","unstructured":"Gnyszka A, Jastrzebski Z, Flis S (2013) DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer. Anticancer Res 33(20):2989\u20132996. https:\/\/doi.org\/10.1093\/jnci\/dji311","journal-title":"Anticancer Res"},{"issue":"19 Pt 1","key":"10837_CR24","doi-asserted-by":"publisher","first-page":"7033","DOI":"10.1158\/1078-0432.CCR-05-0406","volume":"11","author":"MZ Fang","year":"2005","unstructured":"Fang MZ, Chen D, Sun Y, Jin Z, Christman JK, Yang CS (2005) Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 11(19 Pt 1):7033\u20137041. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-0406","journal-title":"Clin Cancer Res"},{"issue":"22","key":"10837_CR25","first-page":"7563","volume":"63","author":"MZ Fang","year":"2003","unstructured":"Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W, Yang CS (2003) Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 63(22):7563\u20137570","journal-title":"Cancer Res"},{"issue":"33","key":"10837_CR26","doi-asserted-by":"publisher","first-page":"23858","DOI":"10.1074\/jbc.M113.480517","volume":"288","author":"RL Fagan","year":"2013","unstructured":"Fagan RL, Cryderman DE, Kopelovich L, Wallrath LL, Brenner C (2013) Laccaic acid a is a direct, dna-competitive inhibitor of DNA methyltransferase 1. J Biol Chem 288(33):23858\u201323867. https:\/\/doi.org\/10.1074\/jbc.M113.480517","journal-title":"J Biol Chem"},{"key":"10837_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-2407-5-44","volume":"5","author":"P Zambrano","year":"2005","unstructured":"Zambrano P, Segura-Pacheco B, Perez-Cardenas E, Cetina L, Revilla-Vazquez A, Taja-Chayeb L, Chavez-Blanco A, Angeles E, Cabrera G, Sandoval K, Trejo-Becerril C, Chanona-Vilchis J, Duenas-Gonz\u00e1lez A (2005) A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes. BMC Cancer 5:44. https:\/\/doi.org\/10.1186\/1471-2407-5-44","journal-title":"BMC Cancer"},{"issue":"16","key":"10837_CR28","first-page":"4984","volume":"63","author":"A Villar-Garea","year":"2003","unstructured":"Villar-Garea A, Fraga MF, Espada J, Esteller M (2003) Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells. Cancer Res 63(16):4984\u20134989","journal-title":"Cancer Res"},{"issue":"7","key":"10837_CR29","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.4049\/jimmunol.140.7.2197","volume":"140","author":"E Cornacchia","year":"1988","unstructured":"Cornacchia E, Golbus J, Maybaum J, Strahler J, Hanash S, Richardson B (1988) Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J Immunol 140(7):2197\u20132200","journal-title":"J Immunol"},{"issue":"2","key":"10837_CR30","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1021\/jm050844z","volume":"49","author":"P Siedlecki","year":"2006","unstructured":"Siedlecki P, Boy RG, Musch T, Brueckner B, Suhai S, Lyko F, Zielenkiewicz P (2006) Discovery of two novel, small-molecule inhibitors of DNA methylation. J Med Chem 49(2):678\u2013683. https:\/\/doi.org\/10.1021\/jm050844z","journal-title":"J Med Chem"},{"issue":"14","key":"10837_CR31","doi-asserted-by":"publisher","first-page":"6305","DOI":"10.1158\/0008-5472.CAN-04-2957","volume":"65","author":"B Brueckner","year":"2005","unstructured":"Brueckner B, Garcia Boy R, Siedlecki P, Musch T, Kliem HC, Zielenkiewicz P, Suhai S, Wiessler M, Lyko F (2005) Epigenetic Reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. Cancer Res 65(14):6305\u20136311. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-2957","journal-title":"Cancer Res"},{"issue":"10","key":"10837_CR32","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1158\/0008-5472.CAN-08-3669","volume":"69","author":"J Datta","year":"2009","unstructured":"Datta J, Ghoshal K, Denny WA, Gamage SA, Brooke DG, Phiasivongsa P, Redkar S, Jacob ST (2009) A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation. Cancer Res 69(10):4277\u20134285. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-3669","journal-title":"Cancer Res"},{"issue":"11","key":"10837_CR33","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1016\/j.biochi.2012.07.025","volume":"94","author":"C Gros","year":"2012","unstructured":"Gros C, Fahy J, Halby L, Dufau I, Erdmann A, Gregoire JM, Ausseil F, Visp\u00e9 S, Arimondo PB (2012) DNA methylation inhibitors in cancer: recent and future approaches. Biochimie 94(11):2280\u20132296. https:\/\/doi.org\/10.1016\/j.biochi.2012.07.025","journal-title":"Biochimie"},{"issue":"5","key":"10837_CR34","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/cmdc.200900017","volume":"4","author":"N Singh","year":"2009","unstructured":"Singh N, Due\u00f1as-Gonz\u00e1lez A, Lyko F, Medina-Franco JL (2009) Molecular modeling and molecular dynamics studies of hydralazine with human DNA methyltransferase 1. ChemMedChem 4(5):792\u2013799. https:\/\/doi.org\/10.1002\/cmdc.200900017","journal-title":"ChemMedChem"},{"key":"10837_CR35","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jmgm.2017.05.014","volume":"75","author":"S Krishna","year":"2017","unstructured":"Krishna S, Shukla S, Lakra AD, Meeran SM, Siddiqi MI (2017) Identification of potent inhibitors of DNA methyltransferase 1 (DNMT1) through a pharmacophore-based virtual screening approach. J Mol Graph Model 75:174\u2013188. https:\/\/doi.org\/10.1016\/j.jmgm.2017.05.014","journal-title":"J Mol Graph Model"},{"issue":"2","key":"10837_CR36","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.bmc.2009.11.050","volume":"18","author":"D Kuck","year":"2010","unstructured":"Kuck D, Singh N, Lyko F, Medina-Franco JL (2010) Novel and selective DNA methyltransferase inhibitors: docking-based virtual screening and experimental evaluation. Bioorg Med Chem 18(2):822\u2013829. https:\/\/doi.org\/10.1016\/j.bmc.2009.11.050","journal-title":"Bioorg Med Chem"},{"issue":"14","key":"10837_CR37","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1021\/jm040031v","volume":"47","author":"DA Erlanson","year":"2004","unstructured":"Erlanson DA, McDowell RS, O\u2019Brien T (2004) Fragment-based drug discovery. J Med Chem 47(14):3463\u20133482. https:\/\/doi.org\/10.1021\/jm040031v","journal-title":"J Med Chem"},{"issue":"12","key":"10837_CR38","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/1062936X.2019.1666165","volume":"30","author":"N Coronado-Posada","year":"2019","unstructured":"Coronado-Posada N, Olivero-Verbel J (2019) In silico evaluation of pesticides as potential modulators of human DNA methyltransferases. SAR QSAR Environ Res 30(12):865\u2013878. https:\/\/doi.org\/10.1080\/1062936X.2019.1666165","journal-title":"SAR QSAR Environ Res"},{"key":"10837_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jmgm.2015.04.010","volume":"60","author":"W Maldonado-Rojas","year":"2015","unstructured":"Maldonado-Rojas W, Olivero-Verbel J, Marrero-Ponce Y (2015) Computational fishing of new DNA methyltransferase inhibitors from natural products. J Mol Graph Model 60:43\u201354. https:\/\/doi.org\/10.1016\/j.jmgm.2015.04.010","journal-title":"J Mol Graph Model"},{"issue":"7","key":"10837_CR40","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1080\/07391102.2017.1337590","volume":"36","author":"P Manoharan","year":"2018","unstructured":"Manoharan P, Ghoshal N (2018) Fragment-based virtual screening approach and molecular dynamics simulation studies for identification of BACE1 inhibitor leads. J Biomol Struct Dyn 36(7):1878\u20131892. https:\/\/doi.org\/10.1080\/07391102.2017.1337590","journal-title":"J Biomol Struct Dyn"},{"issue":"3","key":"10837_CR41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nchem.217","volume":"1","author":"CW Murray","year":"2009","unstructured":"Murray CW, Rees DC (2009) The rise of fragment-based drug discovery. Nature Chem 1(3):187\u2013192. https:\/\/doi.org\/10.1038\/nchem.217","journal-title":"Nature Chem"},{"key":"10837_CR42","unstructured":"Maestro Version 13.0, Schrodinger, LLC, New York, NY, 2021\u20134."},{"issue":"2","key":"10837_CR43","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1021\/jm401419p","volume":"57","author":"S Asgatay","year":"2014","unstructured":"Asgatay S, Champion C, Marloie G, Drujon T, Senamaud-Beaufort C, Ceccaldi A, Erdmann A, Rajavelu A, Schambel P, Jeltsch A, Lequin O, Karoyan P, Arimondo PB, Guianvarc\u2019h D (2014) Synthesis and evaluation of analogues of N -Phthaloyl- l -Tryptophan (RG108) as inhibitors of DNA methyltransferase 1. J Med Chem 57(2):421\u2013434. https:\/\/doi.org\/10.1021\/jm401419p","journal-title":"J Med Chem"},{"issue":"3","key":"10837_CR44","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1021\/jm4012627","volume":"57","author":"S Valente","year":"2014","unstructured":"Valente S, Liu Y, Schnekenburger M, Zwergel C, Cosconati S, Gros C, Tardugno M, Labella D, Florean C, Minden S, Hashimoto H, Chang Y, Zhang X, Kirsch G, Novellino E, Arimondo PB, Miele E, Ferretti E, Gulino A, Diederich M, Cheng X, Mai A (2014) Selective non-nucleoside inhibitors of human DNA methyltransferases active in cancer including in cancer stem cells. J Med Chem 57(3):701\u2013713. https:\/\/doi.org\/10.1021\/jm4012627","journal-title":"J Med Chem"},{"issue":"10","key":"10837_CR45","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1016\/j.bmcl.2009.03.113","volume":"19","author":"OM Saavedra","year":"2009","unstructured":"Saavedra OM, Isakovic L, Llewellyn DB, Zhan L, Bernstein N, Claridge S, Raeppel F, Vaisburg A, Elowe N, Petschner AJ, Rahil J, Beaulieu N, MacLeod AR, Delorme D, Besterman JM, Wahhab A (2009) SAR around (l)-S-adenosyl-l-homocysteine, an inhibitor of human DNA methyltransferase (DNMT) enzymes. Bioorg Med Chem Lett 19(10):2747\u20132751. https:\/\/doi.org\/10.1016\/j.bmcl.2009.03.113","journal-title":"Bioorg Med Chem Lett"},{"issue":"10","key":"10837_CR46","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1016\/j.bmcl.2009.03.132","volume":"19","author":"L Isakovic","year":"2009","unstructured":"Isakovic L, Saavedra OM, Llewellyn DB, Claridge S, Zhan L, Bernstein N, Vaisburg A, Elowe N, Petschner AJ, Rahil J, Beaulieu N, Gauthier F, MacLeod AR, Delorme D, Besterman JM, Wahhab A (2009) Constrained (l-)-S-adenosyl-l-homocysteine (SAH) analogues as DNA methyltransferase inhibitors. Bioorg Med Chem Lett 19(10):2742\u20132746. https:\/\/doi.org\/10.1016\/j.bmcl.2009.03.132","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10837_CR47","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1080\/14756366.2022.2079640","volume":"37","author":"E Li","year":"2022","unstructured":"Li E, Wang K, Zhang B, Guo S, Xiao S, Pan Q, Wang X, Chen W, Wu Y, Xu H, Kong X, Luo C, Chen S, Liu B (2022) Design, synthesis, and biological evaluation of novel carbazole derivatives as potent DNMT1 inhibitors with reasonable PK properties. J Enz Inhib Med Chem 37(1):1537\u20131555. https:\/\/doi.org\/10.1080\/14756366.2022.2079640","journal-title":"J Enz Inhib Med Chem"},{"issue":"21","key":"10837_CR48","doi-asserted-by":"publisher","first-page":"7663","DOI":"10.1021\/jm2010404","volume":"54","author":"S Castellano","year":"2011","unstructured":"Castellano S, Kuck D, Viviano M, Yoo J, L\u00f3pez-Vallejo F, Conti P, Tamborini L, Pinto A, Medina-Franco JL, Sbardella G (2011) Synthesis and biochemical evaluation of \u03942 -isoxazoline derivatives as dna methyltransferase 1 inhibitors. J Med Chem 54(21):7663\u20137677. https:\/\/doi.org\/10.1021\/jm2010404","journal-title":"J Med Chem"},{"issue":"27","key":"10837_CR49","doi-asserted-by":"publisher","first-page":"19673","DOI":"10.1074\/jbc.M112.443895","volume":"288","author":"JA Kilgore","year":"2013","unstructured":"Kilgore JA, Du X, Melito L, Wei S, Wang C, Chin HG, Posner B, Pradhan S, Ready JM, Williams NS (2013) Identification of DNMT1 selective antagonists using a novel scintillation proximity assay. J Biol Chem 288(27):19673\u201319684. https:\/\/doi.org\/10.1074\/jbc.M112.443895","journal-title":"J Biol Chem"},{"issue":"9","key":"10837_CR50","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.3390\/molecules27092892","volume":"27","author":"JL Medina-Franco","year":"2022","unstructured":"Medina-Franco JL, L\u00f3pez-L\u00f3pez E, Mart\u00ednez-Fern\u00e1ndez L (2022) 7-Aminoalkoxy-quinazolines from epigenetic focused libraries are potent and selective inhibitors of DNA methyltransferase 1. Molecules 27(9):2892. https:\/\/doi.org\/10.3390\/molecules27092892","journal-title":"Molecules"},{"key":"10837_CR51","doi-asserted-by":"publisher","unstructured":"Yoo J, Kim JH, Robertson KD, Medina-Franco JL (2012) Molecular modeling of inhibitors of human DNA methyltransferase with a crystal structure. In: Advances in protein chemistry and structural biology; Elsevier, vol 87, pp 219\u2013247. https:\/\/doi.org\/10.1016\/B978-0-12-398312-1.00008-1.","DOI":"10.1016\/B978-0-12-398312-1.00008-1"},{"issue":"4","key":"10837_CR52","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s00894-011-1191-4","volume":"18","author":"J Yoo","year":"2012","unstructured":"Yoo J, Medina-Franco JL (2012) Trimethylaurintricarboxylic acid inhibits human DNA methyltransferase 1: insights from enzymatic and molecular modeling studies. J Mol Model 18(4):1583\u20131589. https:\/\/doi.org\/10.1007\/s00894-011-1191-4","journal-title":"J Mol Model"},{"issue":"2","key":"10837_CR53","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11030-010-9262-5","volume":"15","author":"JL Medina-Franco","year":"2011","unstructured":"Medina-Franco JL, L\u00f3pez-Vallejo F, Kuck D, Lyko F (2011) Natural products as DNA methyltransferase inhibitors: a computer-aided discovery approach. Mol Divers 15(2):293\u2013304. https:\/\/doi.org\/10.1007\/s11030-010-9262-5","journal-title":"Mol Divers"},{"issue":"7","key":"10837_CR54","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.3324\/haematol.2020.248658","volume":"106","author":"AG Gilmartin","year":"2020","unstructured":"Gilmartin AG, Groy A, Gore ER, Atkins C, Long ER, Montoute MN, Wu Z, Halsey W, McNulty DE, Ennulat D, Rueda L, Pappalardi M, Kruger RG, McCabe MT, Raoof A, Butlin R, Stowell A, Cockerill M, Waddell I, Ogilvie D, Luengo J, Jordan A, Benowitz AB (2020) In vitro and in vivo induction of fetal hemoglobin with a reversible and selective DNMT1 inhibitor. Haematologica 106(7):1979\u20131987. https:\/\/doi.org\/10.3324\/haematol.2020.248658","journal-title":"Haematologica"},{"issue":"1","key":"10837_CR55","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13072-021-00429-0","volume":"14","author":"NA Portilho","year":"2021","unstructured":"Portilho NA, Deepak D, Hossain I, Sirois J, Moraes C, Pastor WA (2021) The DNMT1 inhibitor GSK-3484862 mediates global demethylation in murine embryonic stem cells. Epigenet Chromat 14(1):56. https:\/\/doi.org\/10.1186\/s13072-021-00429-0","journal-title":"Epigenet Chromat"},{"issue":"10","key":"10837_CR56","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/s43018-021-00249-x","volume":"2","author":"MB Pappalardi","year":"2021","unstructured":"Pappalardi MB, Keenan K, Cockerill M, Kellner WA, Stowell A, Sherk C, Wong K, Pathuri S, Briand J, Steidel M, Chapman P, Groy A, Wiseman AK, McHugh CF, Campobasso N, Graves AP, Fairweather E, Werner T, Raoof A, Butlin RJ, Rueda L, Horton JR, Fosbenner DT, Zhang C, Handler JL, Muliaditan M, Mebrahtu M, Jaworski JP, McNulty DE, Burt C, Eberl HC, Taylor AN, Ho T, Merrihew S, Foley SW, Rutkowska A, Li M, Romeril SP, Goldberg K, Zhang X, Kershaw CS, Bantscheff M, Jurewicz AJ, Minthorn E, Grandi P, Patel M, Benowitz AB, Mohammad HP, Gilmartin AG, Prinjha RK, Ogilvie D, Carpenter C, Heerding D, Baylin SB, Jones PA, Cheng X, King BW, Luengo JI, Jordan AM, Waddell I, Kruger RG, McCabe MT (2021) Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia. Nat Cancer 2(10):1002\u20131017. https:\/\/doi.org\/10.1038\/s43018-021-00249-x","journal-title":"Nat Cancer"},{"issue":"3","key":"10837_CR57","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.bmcl.2008.12.041","volume":"19","author":"Z Liu","year":"2009","unstructured":"Liu Z, Xie Z, Jones W, Pavlovicz RE, Liu S, Yu J, Li P, Lin J, Fuchs JR, Marcucci G, Li C, Chan KK (2009) Curcumin is a potent dna hypomethylation agent. Bioorg Med Chem Lett 19(3):706\u2013709. https:\/\/doi.org\/10.1016\/j.bmcl.2008.12.041","journal-title":"Bioorg Med Chem Lett"},{"key":"10837_CR58","unstructured":"2D Sketcher Tool, Schrodinger, LLC, New York, NY, 2021\u20134."},{"key":"10837_CR59","unstructured":"LigPrep 13.0, Schrodinger, LLC, New York, NY, 2021\u20134."},{"key":"10837_CR60","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s00044-016-1728-2","volume":"26","author":"P Mahajan","year":"2017","unstructured":"Mahajan P, Suri N, Mehra R, Gupta M, Kumar A, Singh SK, Nargotra A (2017) Discovery of novel small molecule EGFR inhibitory leads by structure and ligand-based virtual screening. Med Chem Res 26:74\u201392. https:\/\/doi.org\/10.1007\/s00044-016-1728-2","journal-title":"Med Chem Res"},{"key":"10837_CR61","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00044-010-9520-1","volume":"21","author":"SV Jain","year":"2012","unstructured":"Jain SV, Sonawane LV, Patil RR, Bari SB (2012) Pharmacophore modeling of some novel indole \u03b2-diketo acid and coumarin-based derivatives as HIV integrase inhibitors. Med Chem Res 21:165\u2013173. https:\/\/doi.org\/10.1007\/s00044-010-9520-1","journal-title":"Med Chem Res"},{"issue":"12","key":"10837_CR62","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1080\/1062936X.2022.2155241","volume":"33","author":"S Banerjee","year":"2022","unstructured":"Banerjee S, Baidya SK, Adhikari N, Jha T (2022) A comparative quantitative structural assessment of benzothiazine-derived HDAC8 inhibitors by predictive ligand-based drug designing approaches. SAR QSAR Environ Res 33(12):987\u20131011. https:\/\/doi.org\/10.1080\/1062936X.2022.2155241. (Epub 2022 Dec 19 PMID: 36533308)","journal-title":"SAR QSAR Environ Res"},{"key":"10837_CR63","unstructured":"PHASE Version 13.0, Schrodinger, LLC, New York, NY, 2021\u20134."},{"key":"10837_CR64","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00044-013-0750-x","volume":"23","author":"N Frimayanti","year":"2014","unstructured":"Frimayanti N, Lee VS, Zain SM, Wahab HA, Rahman NA (2014) 2D, 3D-QSAR, and pharmacophore studies on thiazolidine-4-carboxylic acid derivatives as neuraminidase inhibitors in H3N2 influenza virus. Med Chem Res 23:1447\u20131453. https:\/\/doi.org\/10.1007\/s00044-013-0750-x","journal-title":"Med Chem Res"},{"key":"10837_CR65","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00044-012-0053-7","volume":"22","author":"V Suryanarayanan","year":"2013","unstructured":"Suryanarayanan V, Sudha A, Rajamanikandan S, Vanajothi R, Srinivasan P (2013) Atom-based 3D QSAR studies on novel N-\u03b2-d-Xylosylindole derivatives as SGLT2 inhibitors. Med Chem Res 22:615\u2013624. https:\/\/doi.org\/10.1007\/s00044-012-0053-7","journal-title":"Med Chem Res"},{"key":"10837_CR66","doi-asserted-by":"publisher","first-page":"107481","DOI":"10.1016\/j.compbiomed.2023.107481","volume":"166","author":"G Lanka","year":"2023","unstructured":"Lanka G, Begum D, Banerjee S, Adhikari N, Yogeeswari P, Ghosh B (2023) Pharmacophore-based virtual screening 3D QSAR, Docking, ADMET, and MD simulation studies: an in silico perspective for the identification of new potential HDAC3 inhibitors. Comput Biol Med 166:107481. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.107481","journal-title":"Comput Biol Med"},{"issue":"4","key":"10837_CR67","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3109\/10799893.2013.789912","volume":"33","author":"KK Reddy","year":"2013","unstructured":"Reddy KK, Singh SK, Tripathi SK, Selvaraj C, Suryanarayanan V (2013) Shape and pharmacophore-based virtual screening to identify potential cytochrome P450 sterol 14\u03b1-Demethylase inhibitors. J Recept Signal Transduc 33(4):234\u2013243. https:\/\/doi.org\/10.3109\/10799893.2013.789912","journal-title":"J Recept Signal Transduc"},{"key":"10837_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2021.107509","volume":"93","author":"U Panwar","year":"2021","unstructured":"Panwar U, Singh SK (2021) In silico virtual screening of potent inhibitor to hamper the interaction between HIV-1 integrase and LEDGF\/P75 interaction using e-pharmacophore modeling, molecular docking, and dynamics simulations. Comput Biol Chem 93:107509. https:\/\/doi.org\/10.1016\/j.compbiolchem.2021.107509","journal-title":"Comput Biol Chem"},{"key":"10837_CR69","unstructured":"Enamine database, https:\/\/enamine.net\/compound-collections\/real-compounds\/real-database"},{"key":"10837_CR70","unstructured":"FCH Database, http:\/\/fchgroup.net\/."},{"key":"10837_CR71","unstructured":"Chemdiv Database, https:\/\/www.chemdiv.scom\/."},{"key":"10837_CR72","unstructured":"Life Chemicals Database, https:\/\/lifechemicals.com\/."},{"key":"10837_CR73","unstructured":"Asinex Database, https:\/\/www.asinex.com\/."},{"key":"10837_CR74","unstructured":"Protein Preparation Wizard; Epik, Schrodinger, LLC, New York, NY, 2022\u20131."},{"key":"10837_CR75","unstructured":"Receptor Grid Generation Panel 13.0, Schrodinger, LLC, New York, NY, 2022\u20131."},{"issue":"10","key":"10837_CR76","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"R.A. Laskowski RA, M.B. Swindells M","year":"2011","unstructured":"R.A. Laskowski RA, M.B. Swindells MB, (2011) LigPlot+: multiple ligand\u2013protein interaction diagrams for drug discovery. J Chem Inf Model 51(10):2778\u20132786. https:\/\/doi.org\/10.1021\/ci200227u","journal-title":"J Chem Inf Model"},{"issue":"6020","key":"10837_CR77","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1126\/science.1195380","volume":"331","author":"J Song","year":"2011","unstructured":"Song J, Rechkoblit O, Bestor TH, Patel DJ (2011) Structure of DNMT1-DNA complex reveals a role for autoinhibition in maintenance DNA methylation. Science 331(6020):1036\u20131040. https:\/\/doi.org\/10.1126\/science.1195380","journal-title":"Science"},{"key":"10837_CR78","unstructured":"Glide Version 13.0, Schrodinger, LLC, New York, NY, 2021\u20134."},{"issue":"1","key":"10837_CR79","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40203-021-00108-8","volume":"9","author":"OO Elekofehinti","year":"2021","unstructured":"Elekofehinti OO, Iwaloye O, Olawale F, Chukwuemeka PO, Folorunso IM (2021) Newly designed compounds from scaffolds of known actives as inhibitors of survivin: computational analysis from the perspective of fragment-based drug design. In Silico Pharmacol 9(1):47. https:\/\/doi.org\/10.1007\/s40203-021-00108-8","journal-title":"In Silico Pharmacol"},{"issue":"3","key":"10837_CR80","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/10799893.2019.1660897","volume":"39","author":"G Lanka","year":"2019","unstructured":"Lanka G, Bathula R, Dasari M, Nakkala S, Bhargavi M, Somadi G, Potlapally SR (2019) Structure-based identification of potential novel inhibitors targeting FAM3B (PANDER) causing type 2 diabetes mellitus through virtual screening. J Receptor Signal Transduc 39(3):253\u2013263. https:\/\/doi.org\/10.1080\/10799893.2019.1660897","journal-title":"J Receptor Signal Transduc"},{"key":"10837_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jics.2022.100531","volume":"99","author":"G Lanka","year":"2022","unstructured":"Lanka G, Bhargavi M, Bathula R, Potlapally SR (2022) Targeting tribbles homolog 3 (TRIB3) protein against type 2 diabetes for the identification of potential inhibitors by in silico screening. J Ind Chem Soc 99:100531. https:\/\/doi.org\/10.1016\/j.jics.2022.100531","journal-title":"J Ind Chem Soc"},{"key":"10837_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.aichem.2023.100015","volume":"1","author":"G Lanka","year":"2023","unstructured":"Lanka G, Bathula R, Ghosh B, Potlapally SR (2023) Identification of potential antiviral lead inhibitors against SARS-CoV-2 Main protease: structure-guided virtual screening, docking, ADME, and MD simulation based approach. Artificial Intell Chem 1:100015. https:\/\/doi.org\/10.1016\/j.aichem.2023.100015","journal-title":"Artificial Intell Chem"},{"key":"10837_CR83","unstructured":"Prime Version 13.0, Schrodinger, LLC, New York, NY, 2022\u20131."},{"key":"10837_CR84","unstructured":"QikProp 13.0, Schrodinger, LLC, New York, NY, 2022\u20131."},{"key":"10837_CR85","unstructured":"Desmond 13.1, Schrodinger, LLC, New York, NY, 2022\u20131."},{"key":"10837_CR86","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10837-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-024-10837-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10837-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T16:41:26Z","timestamp":1738341686000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-024-10837-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,18]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10837"],"URL":"https:\/\/doi.org\/10.1007\/s11030-024-10837-5","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,18]]},"assertion":[{"value":"29 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}